(a) Pro Forma Financial statements

The Company is filing herewith as Exhibit 99.2 the following Unaudited Pro Forma Condensed Combined Financial Information prepared to give effect to the Company's acquisition of Cardiocore. The pro forma financial statements include:

†                      Overview

†                      Unaudited Pro Forma Condensed Combined Statement of
Operations for the six months ended June 30, 2012

†                      Unaudited Pro Forma Condensed Combined Statement of
Operations for the twelve months ended December 31, 2011

†                      Notes to Unaudited Pro Forma Condensed Combined Financial
Statements

(b) Financial statements

The Company is filing herewith as Exhibits 99.3 and 99.4 the following financial statements in accordance with Regulation S-X Rules 3-01, 3-02 and 3-05:

† Audited financial statements of Cardiocore as of December 31, 2011 and for the year then ended and;

† Unaudited interim financial statements of Cardiocore as of June 30, 2012 and for the six months then ended

Cautionary Note Regarding Forward-Looking Statements. Except for historical information these statements are provided for informational and illustrative purposes and is preliminary based on currently available information, which we believe is reasonable, but may be subject to change and differ materially from these statements. This pro forma information does not purport to project the future consolidated financial condition or results of operations for the combined company. The Unaudited Pro Forma Condensed Combined Financial Information contains forward-looking statements that involve certain risks and uncertainties that could cause actual results to differ materially from those expressed or implied by these statements. Please refer to the cautionary notes in the Unaudited Pro Forma Condensed Combined Financial Information regarding these forward-looking statements.

(d) Exhibits

Exhibit
Number                                  Description
23.1 ±    Consent of Grant Thornton LLP, Independent Certified Public Accountants
99.1 *    Form 8-K, filed August 30, 2012.
99.2 ±    Unaudited Pro Forma Condensed Combined Financial Information of
          CardioNet, Inc.
99.3 ±    Audited financial statements of Cardiocore Lab, Inc. and Subsidiary as
          of December 31, 2011 for the year then ended
99.4 ±    Unaudited interim financial statements of Cardiocore as of June 30,
          2012 and for the six months then ended

± Filed herewith.